Suppression of GLI1/2 by RNA interference approaches or GANT61, a GLI inhibitor, resulted in a decrease in expression of ABCC1 or ABCB2, and partially restored the chemosensitivity in these poorly differentiated hepatoma cells [16,17]. Here, TAP1 is linked to hepatocellular carcinoma.